Literature DB >> 9580273

Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation.

T Harkany1, S O'Mahony, J P Kelly, K Soós, I Törõ, B Penke, P G Luiten, C Nyakas, K Gulya, B E Leonard.   

Abstract

Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergic fibers projecting to the parietal cortex were investigated after bilateral injections of beta-amyloid(Phe(SO3H)24)25-35 peptide in rat nucleus basalis magnocellularis (nbm). The beta-amyloid peptide used in these experiments contained the original beta-amyloid 25-35 sequence which was coupled to a phenylalanine-sulphonate group at position 24. This additional residue serves as a protective cap on the molecule without influencing its neurotoxic properties and results in water-solubility, stability and low rates of peptide metabolism. In this paper, home cage, locomotor and open-field activities, passive shock-avoidance and 'Morris' water maze learning abilities were assessed throughout a 35-day survival period. Subsequently, acetylcholinesterase (AChE) histochemistry was used to visualize alterations of parietal cortical cholinergic innervation. In response to the neurotoxic action of beta-amyloid(Phe(SO3H)24)25-35, a progressive hyperactivity developed in the rats in their home cages which were maintained throughout the 5-week post-injection period. This was accompanied by a significant hypoactivity in the novel environment of a locomotor arena. Beta-amyloid(Phe(SO3H)24)25-35-treated animals showed greatly impaired cortical memory functions in the step-through passive shock-avoidance paradigm, while spatial learning processes remained unaffected. Moreover, beta-amyloid(Phe(SO3H)24)25-35 injections in the nucleus basalis suppressed explorative behavior in rats and inhibited conditioned stress responses 28 days after surgery. Reductions of cortical cholinergic (AChE-positive) projections provided anatomical substrate for the behavioral changes. This indicated extensive, long-lasting neurodegenerative processes as a result of beta-amyloid(Phe(SO3H)24)25-35 infusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580273     DOI: 10.1016/s0166-4328(97)00091-0

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

Review 1.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Postischemic administration of HLDF-6 peptide ameliorates cognitive dysfunction and brain damage induced by chronic cerebral ischemia in rats.

Authors:  I A Kostanyan; Z I Storozheva; N A Semenova; V M Lipkin
Journal:  Dokl Biol Sci       Date:  2009 Sep-Oct

Review 3.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

4.  Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.

Authors:  K Yamada; T Tanaka; T Mamiya; T Shiotani; T Kameyama; T Nabeshima
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer's disease rat model.

Authors:  Xiaojuan Han; Yan Ma; Xiaohui Liu; Lu Wang; Shen Qi; Qinghua Zhang; Yifeng Du
Journal:  J Neural Transm (Vienna)       Date:  2012-04-17       Impact factor: 3.575

Review 6.  Acetylcholine receptors in dementia and mild cognitive impairment.

Authors:  Osama Sabri; Kai Kendziorra; Henrike Wolf; Hermann-Josef Gertz; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

7.  Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models.

Authors:  Jin Young Shin; Hyun Jung Park; Ha Na Kim; Se Hee Oh; Jae-Sung Bae; Hee-Jin Ha; Phil Hyu Lee
Journal:  Autophagy       Date:  2013-01-01       Impact factor: 16.016

Review 8.  Intracellular A-beta amyloid, a sign for worse things to come?

Authors:  Valentina Echeverria; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

9.  Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia.

Authors:  Zinaida I Storozheva; Andrey T Proshin; Vladimir V Sherstnev; Tatiana P Storozhevykh; Yana E Senilova; Nadezhda A Persiyantseva; Vsevolod G Pinelis; Natalia A Semenova; Elena I Zakharova; Igor A Pomytkin
Journal:  BMC Pharmacol       Date:  2008-01-23

10.  The rat as an animal model of Alzheimer's disease.

Authors:  Eirikur Benedikz; Ewa Kloskowska; Bengt Winblad
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.